PALLD
PALLD (palladin, cytoskeletal associated protein) is a cytoskeletal protein required for the organisation of the normal actin cytoskeleton. It is also known as KIAA0992, SIH002 and CGI-151, and belongs to the myotilin/palladin family. Browse Assay Genie's current range of PALLD research reagents below, or read on for the biology behind the target.
PALLD is a cytoskeletal protein that is required for the organisation of the normal actin cytoskeleton. It contributes to establishing cell morphology, motility, cell adhesion and cell-extracellular matrix interactions in a variety of cell types. It may act as a scaffolding molecule with the potential to influence both actin polymerisation and the assembly of existing actin filaments into higher-order arrays. PALLD binds to proteins that bind either monomeric or filamentous actin, and it is involved in targeting ACTN to specific subcellular foci.
The PALLD protein is a component of actin-containing microfilaments and is involved in the control of cell shape, adhesion and contraction. It localises to sites of active actin remodelling, such as lamellipodia and membrane ruffles, and is also found in focal adhesions, podosomes, the Z line of sarcomeres, and in axons and growth cones. The PALLD gene is classed by HGNC in the I-set domain containing group, and the protein belongs to the myotilin/palladin family. Alternative splicing produces multiple transcript variants, and different isoforms may have functional differences.
PALLD is involved in the control of the morphological and cytoskeletal changes associated with dendritic cell maturation. Polymorphisms in the gene are associated with susceptibility to pancreatic cancer type 1 and with a risk of myocardial infarction. The gene was previously catalogued under identifiers such as KIAA0992, SIH002 and CGI-151, and orthologous genes (Palld) are present in mouse and rat.
PALLD is required for organising the actin cytoskeleton and may scaffold actin polymerisation and the assembly of filaments into higher-order arrays.
PALLD contributes to cell morphology, motility, adhesion and cell-extracellular matrix interactions, and localises to lamellipodia and membrane ruffles.
Polymorphisms in the PALLD gene are associated with susceptibility to pancreatic cancer type 1.
PALLD variants are linked to myocardial infarction risk, and the protein is involved in cytoskeletal changes during dendritic cell maturation.
PALLD is a cytoskeletal protein required for organising the actin cytoskeleton. It may act as a scaffold influencing actin polymerisation and filament assembly, binds actin-binding proteins, and helps target ACTN to specific subcellular foci. It supports cell shape, adhesion, motility and contraction.
PALLD, palladin, is also known as KIAA0992, SIH002 and CGI-151. Alternative splicing of the PALLD gene produces multiple transcript variants, and UniProt notes that different isoforms may have functional differences. Check the datasheet of any product for its validated reactivity.
Polymorphisms in PALLD are associated with susceptibility to pancreatic cancer type 1 and with a risk of myocardial infarction. Orthologous genes, named Palld, exist in mouse and rat, so the protein can be studied in common rodent models.
Other actin-binding proteins, cytoskeletal components and focal adhesion markers studied alongside PALLD.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q8WX93; product specifications from Assay Genie datasheets.